mynth
12/2018

ANTELLIQ acquired by MERCK & CO.

FRANCE Life Sciences / Animal Health EV 3b - 100b EUR

Context

The global life sciences leader has finalized the acquisition of 100% of the share capital of the target from a prominent European private equity firm. This strategic transaction represents a definitive move to incorporate advanced digital capabilities into the group’s specialized animal health division, targeting the high-growth segment of animal intelligence and monitoring. The strategic rationale for the move centers on the acquirer's objective to provide integrated, data-driven health management solutions that complement its existing portfolio of vaccines and medicines. By incorporating this technical specialist, the organization reinforces its ability to offer comprehensive traceability and real-time health insights for livestock and companion animals. The partnership is designed to leverage the acquirer’s global reach and research infrastructure to accelerate the development of next-generation monitoring technologies. This integration facilitates the creation of a premier digital platform in the animal health market, providing the strategic depth required to address the rising demand for food security and enhanced pet longevity.

In the past, the company had already been the subject of several LBOs, notably led by Bc Partners in 2013 and Psp Investments in 2016. These multiple LBO cycles illustrate the strong appeal for this type of asset.

ANTELLIQ, which reported an EBITDA margin of in 2018, is valued in this transaction at an EV/EBITDA multiple of , a level than the average currently observed in the Healthcare & Pharma sector (15.6x).

-> Deep-dive in Healthcare & Pharma market trends

Target

Antelliq is a specialized technology organization dedicated to the development and deployment of digital identification, traceability, and monitoring solutions for animals. The entity’s business model focuses on providing high-precision hardware and data analytics to facilitate the management of livestock and companion animals. Its value proposition is anchored in enhancing animal welfare and productivity through real-time health and behavioral insights. Strategically, the firm operates at the intersection of veterinary science and digital reality, utilizing proprietary sensors and tracking software to provide actionable data for farmers and veterinarians. By maintaining a leadership position in the global animal intelligence market, the organization ensures a mission-critical role in the agricultural supply chain and pet care ecosystems. The entity emphasizes industrialized reliability to address the increasing demand for food safety and personalized animal care.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year
Rev
EBITDA
EBIT
2018
2017

Other operations with ANTELLIQ

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
DateAcquirerTargetCountrySector
03/2016PSP INVESTMENTSANTELLIQFRANCEAnimal Health
06/2013BC PARTNERSANTELLIQFRANCEAnimal Health

REFERENCES

Valuation range: EV 3b - 100b EUR

Revenue range: 250M - 500M EUR

EBITDA range: 100M - 200M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of ANTELLIQ by MERCK & CO. are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.